These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 25194444)

  • 1. Telomere 1 (POT1) gene expression and its association with telomerase activity in colorectal tumor samples with different pathological features.
    Izgi A; Gunal A; Yalcin S; Gunduz U
    Biomed Pharmacother; 2014 Sep; 68(7):841-6. PubMed ID: 25194444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human POT1 facilitates telomere elongation by telomerase.
    Colgin LM; Baran K; Baumann P; Cech TR; Reddel RR
    Curr Biol; 2003 May; 13(11):942-6. PubMed ID: 12781132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human POT1 disrupts telomeric G-quadruplexes allowing telomerase extension in vitro.
    Zaug AJ; Podell ER; Cech TR
    Proc Natl Acad Sci U S A; 2005 Aug; 102(31):10864-9. PubMed ID: 16043710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of telomere binding proteins in gastric cancer and correlation with clinicopathological parameters.
    Gao J; Zhang J; Long Y; Lu X
    Asia Pac J Clin Oncol; 2011 Dec; 7(4):339-45. PubMed ID: 22151982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
    Engelhardt M; Drullinsky P; Guillem J; Moore MA
    Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. POT1 deficiency alters telomere length and telomere-associated gene expression in human gastric cancer cells.
    Ning X; Yang S; Wang R; Zhang R; Guo L; Tie J; Cheng Y; Wang G; Wan S; Fang D
    Eur J Cancer Prev; 2010 Sep; 19(5):345-51. PubMed ID: 20517159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rescue of an hTERT mutant defective in telomere elongation by fusion with hPot1.
    Armbruster BN; Linardic CM; Veldman T; Bansal NP; Downie DL; Counter CM
    Mol Cell Biol; 2004 Apr; 24(8):3552-61. PubMed ID: 15060173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human protection of telomeres 1 (POT1) is a negative regulator of telomerase activity in vitro.
    Kelleher C; Kurth I; Lingner J
    Mol Cell Biol; 2005 Jan; 25(2):808-18. PubMed ID: 15632080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnostic significance of telomerase activity and telomere length in endoscopic sample of colorectal cancer].
    Katayama S; Shiota G; Kawasaki H
    Nihon Rinsho; 1998 May; 56(5):1204-8. PubMed ID: 9613123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlations of telomere length, telomerase activity, and telomeric-repeat binding factor 1 expression in colorectal carcinoma.
    Garcia-Aranda C; de Juan C; Diaz-Lopez A; Sanchez-Pernaute A; Torres AJ; Diaz-Rubio E; Balibrea JL; Benito M; Iniesta P
    Cancer; 2006 Feb; 106(3):541-51. PubMed ID: 16388518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomere length and human telomerase reverse transcriptase expression as markers for progression and prognosis of colorectal carcinoma.
    Gertler R; Rosenberg R; Stricker D; Friederichs J; Hoos A; Werner M; Ulm K; Holzmann B; Nekarda H; Siewert JR
    J Clin Oncol; 2004 May; 22(10):1807-14. PubMed ID: 15143073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Switching human telomerase on and off with hPOT1 protein in vitro.
    Lei M; Zaug AJ; Podell ER; Cech TR
    J Biol Chem; 2005 May; 280(21):20449-56. PubMed ID: 15792951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of hPOT1 in diploid human cells results in an hTERT-dependent alteration of telomere length dynamics.
    Possemato R; Timmons JC; Bauerlein EL; Wada N; Baldwin A; Masutomi K; Hahn WC
    Mol Cancer Res; 2008 Oct; 6(10):1582-93. PubMed ID: 18922974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of hPot1 function leads to telomere instability and a cut-like phenotype.
    Veldman T; Etheridge KT; Counter CM
    Curr Biol; 2004 Dec; 14(24):2264-70. PubMed ID: 15620654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of telomeric repeat binding factor 1 and 2 and TRF1-interacting nuclear protein 2 in human gastric carcinomas.
    Matsutani N; Yokozaki H; Tahara E; Tahara H; Kuniyasu H; Haruma K; Chayama K; Yasui W; Tahara E
    Int J Oncol; 2001 Sep; 19(3):507-12. PubMed ID: 11494028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcoma.
    Engelhardt M; Albanell J; Drullinsky P; Han W; Guillem J; Scher HI; Reuter V; Moore MA
    Clin Cancer Res; 1997 Oct; 3(10):1849-57. PubMed ID: 9815573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing of the hPOT1 gene by RNA inference promotes apoptosis and inhibits proliferation and aggressive phenotype of gastric cancer cells, likely through up-regulating PinX1 expression.
    Wan SM; Tie J; Zhang YF; Guo J; Yang LQ; Wang J; Xia SH; Yang SM; Wang RQ; Fang DC
    J Clin Pathol; 2011 Dec; 64(12):1051-7. PubMed ID: 21778296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomere neurobiology.
    Mattson MP; Zhang P; Cheng A
    Methods Mol Biol; 2008; 438():185-96. PubMed ID: 18369758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demonstration of human telomerase reverse transcriptase in human colorectal carcinomas by in situ hybridization.
    Kammori M; Kanauchi H; Nakamura K; Kawahara M; Weber TK; Mafune K; Kaminishi M; Takubo K
    Int J Oncol; 2002 Jan; 20(1):15-21. PubMed ID: 11743637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two faces of Solanaceae telomeres: a comparison between Nicotiana and Cestrum telomeres and telomere-binding proteins.
    Peska V; Sýkorová E; Fajkus J
    Cytogenet Genome Res; 2008; 122(3-4):380-7. PubMed ID: 19188709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.